Insider selling
Traded Oct 15 · filed the same day
A Gilead Sciences officer told the SEC about a plan to sell $469K of Gilead Sciences shares around Oct 15, 2026. The shares were not acquired as compensation.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Sep 15, 2026 · Notice filed Sep 15, 2026
A Gilead Sciences officer told the SEC about a plan to sell $433K of Gilead Sciences shares around Sep 15, 2026. The shares were not acquired as compensation.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider selling
Traded Oct 15 · filed the same day
A Gilead Sciences officer told the SEC about a plan to sell $469K of Gilead Sciences shares around Oct 15, 2026. The shares were not acquired as compensation.
Insider selling
Traded Oct 15 · filed the same day
A Gilead Sciences officer told the SEC about a plan to sell $469K of Gilead Sciences shares around Oct 15, 2026. The shares were not acquired as compensation.
Daniel Patrick O'day (Chairman & CEO) sold ~$1.77M of Gilead Sciences
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.